Making the discoveries that defeat cancer

  • Home »
  • Research »
  • Repository

  • Administrators Login

  • Repository Homepage
  • About the Repository
  • Browse the Repository
  • Search the Repository
  • Contribute an Article
  • Missing Publications
  • Repository Help

Development of Therapeutic Combinations Targeting Major Cancer Signaling Pathways

Tools
- Tools
+ Tools

Yap, T. A., Omlin, A., de Bono, J. S. (2013) Development of Therapeutic Combinations Targeting Major Cancer Signaling Pathways. JOURNAL OF CLINICAL ONCOLOGY, 31 (12). pp. 1592-1605. ISSN 0732-183X

Full text not available from this repository.

Abstract

Development of Therapeutic Combinations Targeting Major Cancer Signaling Pathways

Item Type: Article
Authors (ICR Faculty only): De-Bono, Johann
All Authors: Yap, T. A., Omlin, A., de Bono, J. S.
Additional Information: ISI Document Delivery No.: 129IC Times Cited: 0 Cited Reference Count: 72 Yap, Timothy A. Omlin, Aurelius de Bono, Johann S. Cancer Research UK [C347/A15403]; Experimental Cancer Medicine Centre [C51/A7401, C12540/A15573]; Prostate Cancer Foundation; Scott Minerd Prostate Cancer Foundation Young Investigator Award; Swiss Cancer League [BIL KLS-02592-02-2010] Supported in part by Program Grant No. C347/A15403 from Cancer Research UK to the Drug Development Unit of the Royal Marsden National Health Service Foundation Trust and Institute of Cancer; by Grants No. C51/A7401 and C12540/A15573 from the Experimental Cancer Medicine Centre (to The Institute of Cancer Research); by the Prostate Cancer Foundation; by the 2011 Scott Minerd Prostate Cancer Foundation Young Investigator Award (T.A.Y.); and by a 2-year bursary from the Swiss Cancer League (No. BIL KLS-02592-02-2010) to support current clinical research fellowship (A.O.). Amer soc clinical oncology Alexandria
Uncontrolled Keywords: cell lung-cancer chronic myelogenous leukemia anaplastic lymphoma kinase metastatic breast-cancer randomized phase-ii prostate-cancer monoclonal-antibody increased survival androgen receptor drug development
Research teams: ICR divisions > Cancer Therapeutics > Cancer Biomarkers
ICR divisions > Clinical Studies > Cancer Biomarkers

ICR divisions > Clinical Studies > Prostate Cancer Targeted Therapy Group
Depositing User: Barry Jenkins
Date Deposited: 29 May 2013 09:19
Last Modified: 11 Jul 2017 08:35
URI: http://publications.icr.ac.uk/id/eprint/12462

Actions (login required)

View Item View Item
The Royal Marsden - NHS foundation trust